Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07562152
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
- Locations
-
- City of Hope Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- Medical Oncology Hematology Consultants Newark, Delaware, United States
- Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
NCT07491445
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Honor Health Research Institute Scottsdale, Arizona, United States
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT07621718
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Piedmont Healthcare Atlanta, Georgia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States
NCT07664891
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Locations
-
- Institut Paoli-Calmettes Marseille, France
NCT07377045
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Locations
-
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
- Hospital Universitario Vall d'Hebron (VHIO) Barcelona, Spain
- Hospital Universitario Donostia Donostia / San Sebastian, Spain
- ICO- Hospitalet Catalan Institute of Oncology L'Hospitalet de Llobregat, Spain
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04150042
- Conditions
- Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation, +35 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT07284277
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- Clínica Universidad de Navarra Pamplona, Navarre, Spain
- Hospital Universitario de Cruces Barakaldo, Vizcaya, Spain
- Hospital de Galdakao Galdakao, Vizcaya, Spain
- Fundación Jiménez-Díaz Madrid, Spain
NCT06747845
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT06792435
- Conditions
- Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +35 more
- Locations
-
- Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer
NCT07665684
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenosquamous Carcinoma of the Pancreas, +20 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
NCT07566897
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
- Locations
-
- Fondazione Policlinico Gemelli Unità di Fase 1: Unità di Farmacologia Clinica Roma, Italy
Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
NCT06615830
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
Not specified
NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer
NCT07314385
- Conditions
- Liver Metastasis, Pancreatic Adenocarcinoma Metastatic
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT06006728
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Locations
-
- CHU Bordeaux Pessac, France
NCT01053013
- Conditions
- Colorectal Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Non-resectable
- Locations
-
- Weill Cornell Medical Center / The Rogosin Institute New York, United States
NCT01715142
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- Antwerp University Hospital (UZA) Edegem, Antwerpen, Belgium
- Erasme University Hospital (ULB) Brussels, Belgium
NCT02179970
- Conditions
- Adnexal Diseases, Colonic Diseases, Colorectal Cancer Metastatic, +26 more
- Locations
-
- Addenbrookes Hospital Cambridge, United Kingdom
NCT03529175
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Locations
-
- Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom
- Peterborough City Hospital Peterborough, Cambridgeshire, United Kingdom
- Ysbyty Gwynedd Bangor, United Kingdom
- Belfast City Hospital Belfast, United Kingdom
NCT02195180
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +3 more
- Locations
-
- Saint Catherine Institute Avignon, France
- Institut de Cancerologie Brest, France
- Hopital Beaujon Clichy, France
- Hospital Henri Mondor Créteil, France
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
NCT05077800
- Conditions
- Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Massachusetts General Hospital Charlestown, Massachusetts, United States
- University of Washington School of Medicine Seattle, Washington, United States